Consumer Health in Finland
Consumer health in Finland is seeing moderate current value growth in 2023. On one hand, prices have increased due to inflation, but, at the same time, the poor economic outlook has made consumers cautious in their purchases. Overall, the OTC segment is performing more poorly than other areas of consumer health. This is largely due to the fact that sales of several high-sales categories peaked during the heavy cough and cold season in 2022, as consumers returned to normal social interaction foll...
Euromonitor International's Consumer Health in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Consumer Health in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
CONSUMER HEALTH IN FINLAND
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 2 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2018-2023
Table 4 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 5 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 6 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 8 Distribution of Consumer Health by Format: % Value 2018-2023
Table 9 Distribution of Consumer Health by Format and Category: % Value 2023
Table 10 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Analgesics continues up and down performance
Value-added products emerging, while paediatric analgesics sees healthy performance
Orion Oyj maintains lead
PROSPECTS AND OPPORTUNITIES
Analgesics forecast to see modest growth
Positive outlook for paediatric analgesics
Topical analgesics seeing unit price growth
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2018-2023
Table 13 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 14 NBO Company Shares of Analgesics: % Value 2019-2023
Table 15 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 16 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Slight fall after peak in previous year
Nasal sprays and pharyngeal preparations doing well
Cloetta Suomi Oy benefits from strength of Lдkerol brand
PROSPECTS AND OPPORTUNITIES
Growing demand for convenience
Combination products set to see strong performance
Strong brand recognition and trust to support growth in pharyngeal preparations
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2023
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2023
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2023-2028
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2023-2028
DIGESTIVE REMEDIES IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Revival of normal lifestyles leads to digestive issues
Paediatric diarrhoeal remedies offers novel opportunities
Orion Oyj retains lead, while pharmacy-owned private label continues to emerge
PROSPECTS AND OPPORTUNITIES
Modern lifestyles supporting demand
Growing demand for convenience
Poor outlook for antiflatulents and H2 blockers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2018-2023
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Table 26 NBO Company Shares of Digestive Remedies: % Value 2019-2023
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
DERMATOLOGICALS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Revival of new product development activity boosts sales
Convenience factor proving important, while nappy rash treatments being hit by falling birth rates
Bayer leads, while smaller brands emerge
PROSPECTS AND OPPORTUNITIES
Moderate growth expected
Notable growth for medicated shampoos
Growing competition from products such as dietary supplements
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2018-2023
Table 31 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 32 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 33 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 35 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
NRT SMOKING CESSATION AIDS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Situation unclear after regulatory changes
Increasing interest in spray format
Two players dominate
PROSPECTS AND OPPORTUNITIES
Further decline expected
Situation remains unclear in NRT pouches
Expansion of potential consumer base
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2018-2023
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2019-2023
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2020-2023
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2023-2028
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2023-2028
SLEEP AIDS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Finns looking for melatonin-based products
Return of herbal ingredients and ongoing expansion of grocery retailing
Intense competition
PROSPECTS AND OPPORTUNITIES
Positive outlook underpinned by a variety of factors
Expanding offer of melatonin-based combination products
Revival of interest in herbal sleep aids
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2018-2023
Table 45 Sales of Sleep Aids: % Value Growth 2018-2023
Table 46 NBO Company Shares of Sleep Aids: % Value 2019-2023
Table 47 LBN Brand Shares of Sleep Aids: % Value 2020-2023
Table 48 Forecast Sales of Sleep Aids: Value 2023-2028
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
EYE CARE IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Rise in screen time leads to eye problems
Allergy eye care outperforming standard products
Bayer leads, while local player sees continued share growth
PROSPECTS AND OPPORTUNITIES
Sales set to rise, though intensification of competition may dampen value growth
More standard eye drops in grocery retailing
Expanded offer expected in allergy eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2018-2023
Table 51 Sales of Eye Care by Category: % Value Growth 2018-2023
Table 52 NBO Company Shares of Eye Care: % Value 2019-2023
Table 53 LBN Brand Shares of Eye Care: % Value 2020-2023
Table 54 Forecast Sales of Eye Care by Category: Value 2023-2028
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2023-2028
WOUND CARE IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Inflation drives up value, while volumes fall
Private label benefiting from increased consumer price sensitivity
Orkla and Beiersdorf continue to dominate, but see share loss
PROSPECTS AND OPPORTUNITIES
Moderate growth expected
Opportunities for private label
Brands to become more innovative as economic conditions improve
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2018-2023
Table 57 Sales of Wound Care by Category: % Value Growth 2018-2023
Table 58 NBO Company Shares of Wound Care: % Value 2019-2023
Table 59 LBN Brand Shares of Wound Care: % Value 2020-2023
Table 60 Forecast Sales of Wound Care by Category: Value 2023-2028
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2023-2028
VITAMINS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Vitamins sales stabilising after pandemic peak
Multivitamins working to address challenges, as consumers look to single vitamins
Leader sees share eroded
PROSPECTS AND OPPORTUNITIES
Maturity and shift to grocery channel to constrain growth
Vitamin K expected to perform well
Competition intensifying
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2018-2023
Table 63 Sales of Vitamins by Category: % Value Growth 2018-2023
Table 64 Sales of Multivitamins by Positioning: % Value 2018-2023
Table 65 NBO Company Shares of Vitamins: % Value 2019-2023
Table 66 LBN Brand Shares of Vitamins: % Value 2020-2023
Table 67 Forecast Sales of Vitamins by Category: Value 2023-2028
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2023-2028
DIETARY SUPPLEMENTS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
New product launches with range of claims
New products boost performance of probiotics, while energy and stress relief products do well
Orkla Care leads fragmented category
PROSPECTS AND OPPORTUNITIES
New products set to boost sales
Positive outlook for probiotics
Mineral supplements expected to perform well
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2018-2023
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2018-2023
Table 71 Sales of Dietary Supplements by Positioning: % Value 2018-2023
Table 72 NBO Company Shares of Dietary Supplements: % Value 2019-2023
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2020-2023
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2023-2028
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2023-2028
WEIGHT MANAGEMENT AND WELLBEING IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Falling sales linked to new legislation and shifting health trends
Meal replacement and weight loss supplements performing poorly
Highly fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
Consumer behaviour trends unfavourable for weight management and wellbeing
New Rx product further complicates situation for OTC obesity
Competition from packaged food and sports nutrition
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2019-2023
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2020-2023
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2023-2028
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2023-2028
SPORTS NUTRITION IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Growth across categories
Expanding product offer supports growth
Leading players see continued share erosion
PROSPECTS AND OPPORTUNITIES
Healthy growth expected
Sports non-protein products set to thrive
Opportunities for expansion of sports protein RTDs
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2018-2023
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2018-2023
Table 84 NBO Company Shares of Sports Nutrition: % Value 2019-2023
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2020-2023
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2023-2028
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2023-2028
HERBAL/TRADITIONAL PRODUCTS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Diversification of demand in herbal/traditional products
Product innovation spurring consumer interest
Cloetta Suomi leads fragmented category
PROSPECTS AND OPPORTUNITIES
Potential for growth despite economic challenges
Expansion of herbal sleep aids
Demand for stress relieving products
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2019-2023
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2020-2023
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2023-2028
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2023-2028
PAEDIATRIC CONSUMER HEALTH IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Untapped potential
Digestive remedies and analgesics performing well
GSK Consumer Healthcare extends lead
PROSPECTS AND OPPORTUNITIES
Parents to continue to prioritise spending on children
New products could drive growth
Innovation needs to resonate with convenience trend
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2019-2023
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2020-2023
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2023-2028
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2023-2028
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 2 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2018-2023
Table 4 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 5 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 6 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 8 Distribution of Consumer Health by Format: % Value 2018-2023
Table 9 Distribution of Consumer Health by Format and Category: % Value 2023
Table 10 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Analgesics continues up and down performance
Value-added products emerging, while paediatric analgesics sees healthy performance
Orion Oyj maintains lead
PROSPECTS AND OPPORTUNITIES
Analgesics forecast to see modest growth
Positive outlook for paediatric analgesics
Topical analgesics seeing unit price growth
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2018-2023
Table 13 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 14 NBO Company Shares of Analgesics: % Value 2019-2023
Table 15 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 16 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Slight fall after peak in previous year
Nasal sprays and pharyngeal preparations doing well
Cloetta Suomi Oy benefits from strength of Lдkerol brand
PROSPECTS AND OPPORTUNITIES
Growing demand for convenience
Combination products set to see strong performance
Strong brand recognition and trust to support growth in pharyngeal preparations
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2023
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2023
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2023-2028
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2023-2028
DIGESTIVE REMEDIES IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Revival of normal lifestyles leads to digestive issues
Paediatric diarrhoeal remedies offers novel opportunities
Orion Oyj retains lead, while pharmacy-owned private label continues to emerge
PROSPECTS AND OPPORTUNITIES
Modern lifestyles supporting demand
Growing demand for convenience
Poor outlook for antiflatulents and H2 blockers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2018-2023
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Table 26 NBO Company Shares of Digestive Remedies: % Value 2019-2023
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
DERMATOLOGICALS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Revival of new product development activity boosts sales
Convenience factor proving important, while nappy rash treatments being hit by falling birth rates
Bayer leads, while smaller brands emerge
PROSPECTS AND OPPORTUNITIES
Moderate growth expected
Notable growth for medicated shampoos
Growing competition from products such as dietary supplements
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2018-2023
Table 31 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 32 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 33 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 35 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
NRT SMOKING CESSATION AIDS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Situation unclear after regulatory changes
Increasing interest in spray format
Two players dominate
PROSPECTS AND OPPORTUNITIES
Further decline expected
Situation remains unclear in NRT pouches
Expansion of potential consumer base
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2018-2023
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2019-2023
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2020-2023
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2023-2028
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2023-2028
SLEEP AIDS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Finns looking for melatonin-based products
Return of herbal ingredients and ongoing expansion of grocery retailing
Intense competition
PROSPECTS AND OPPORTUNITIES
Positive outlook underpinned by a variety of factors
Expanding offer of melatonin-based combination products
Revival of interest in herbal sleep aids
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2018-2023
Table 45 Sales of Sleep Aids: % Value Growth 2018-2023
Table 46 NBO Company Shares of Sleep Aids: % Value 2019-2023
Table 47 LBN Brand Shares of Sleep Aids: % Value 2020-2023
Table 48 Forecast Sales of Sleep Aids: Value 2023-2028
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
EYE CARE IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Rise in screen time leads to eye problems
Allergy eye care outperforming standard products
Bayer leads, while local player sees continued share growth
PROSPECTS AND OPPORTUNITIES
Sales set to rise, though intensification of competition may dampen value growth
More standard eye drops in grocery retailing
Expanded offer expected in allergy eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2018-2023
Table 51 Sales of Eye Care by Category: % Value Growth 2018-2023
Table 52 NBO Company Shares of Eye Care: % Value 2019-2023
Table 53 LBN Brand Shares of Eye Care: % Value 2020-2023
Table 54 Forecast Sales of Eye Care by Category: Value 2023-2028
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2023-2028
WOUND CARE IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Inflation drives up value, while volumes fall
Private label benefiting from increased consumer price sensitivity
Orkla and Beiersdorf continue to dominate, but see share loss
PROSPECTS AND OPPORTUNITIES
Moderate growth expected
Opportunities for private label
Brands to become more innovative as economic conditions improve
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2018-2023
Table 57 Sales of Wound Care by Category: % Value Growth 2018-2023
Table 58 NBO Company Shares of Wound Care: % Value 2019-2023
Table 59 LBN Brand Shares of Wound Care: % Value 2020-2023
Table 60 Forecast Sales of Wound Care by Category: Value 2023-2028
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2023-2028
VITAMINS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Vitamins sales stabilising after pandemic peak
Multivitamins working to address challenges, as consumers look to single vitamins
Leader sees share eroded
PROSPECTS AND OPPORTUNITIES
Maturity and shift to grocery channel to constrain growth
Vitamin K expected to perform well
Competition intensifying
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2018-2023
Table 63 Sales of Vitamins by Category: % Value Growth 2018-2023
Table 64 Sales of Multivitamins by Positioning: % Value 2018-2023
Table 65 NBO Company Shares of Vitamins: % Value 2019-2023
Table 66 LBN Brand Shares of Vitamins: % Value 2020-2023
Table 67 Forecast Sales of Vitamins by Category: Value 2023-2028
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2023-2028
DIETARY SUPPLEMENTS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
New product launches with range of claims
New products boost performance of probiotics, while energy and stress relief products do well
Orkla Care leads fragmented category
PROSPECTS AND OPPORTUNITIES
New products set to boost sales
Positive outlook for probiotics
Mineral supplements expected to perform well
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2018-2023
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2018-2023
Table 71 Sales of Dietary Supplements by Positioning: % Value 2018-2023
Table 72 NBO Company Shares of Dietary Supplements: % Value 2019-2023
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2020-2023
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2023-2028
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2023-2028
WEIGHT MANAGEMENT AND WELLBEING IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Falling sales linked to new legislation and shifting health trends
Meal replacement and weight loss supplements performing poorly
Highly fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
Consumer behaviour trends unfavourable for weight management and wellbeing
New Rx product further complicates situation for OTC obesity
Competition from packaged food and sports nutrition
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2019-2023
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2020-2023
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2023-2028
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2023-2028
SPORTS NUTRITION IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Growth across categories
Expanding product offer supports growth
Leading players see continued share erosion
PROSPECTS AND OPPORTUNITIES
Healthy growth expected
Sports non-protein products set to thrive
Opportunities for expansion of sports protein RTDs
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2018-2023
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2018-2023
Table 84 NBO Company Shares of Sports Nutrition: % Value 2019-2023
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2020-2023
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2023-2028
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2023-2028
HERBAL/TRADITIONAL PRODUCTS IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Diversification of demand in herbal/traditional products
Product innovation spurring consumer interest
Cloetta Suomi leads fragmented category
PROSPECTS AND OPPORTUNITIES
Potential for growth despite economic challenges
Expansion of herbal sleep aids
Demand for stress relieving products
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2019-2023
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2020-2023
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2023-2028
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2023-2028
PAEDIATRIC CONSUMER HEALTH IN FINLAND
KEY DATA FINDINGS
2023 DEVELOPMENTS
Untapped potential
Digestive remedies and analgesics performing well
GSK Consumer Healthcare extends lead
PROSPECTS AND OPPORTUNITIES
Parents to continue to prioritise spending on children
New products could drive growth
Innovation needs to resonate with convenience trend
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2019-2023
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2020-2023
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2023-2028
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2023-2028
